Home > Publications Database > Satb1 directs the differentiation of TH17 cells through suppression of IL-2 expression. > print

001     279433
005     20250828101647.0
024 7 _ |a 10.1016/j.celrep.2025.115866
|2 doi
024 7 _ |a pmid:40531625
|2 pmid
024 7 _ |a 2211-1247
|2 ISSN
024 7 _ |a 2639-1856
|2 ISSN
024 7 _ |a altmetric:178196731
|2 altmetric
037 _ _ |a DZNE-2025-00764
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Köhne, Maren
|0 P:(DE-2719)2812698
|b 0
|u dzne
245 _ _ |a Satb1 directs the differentiation of TH17 cells through suppression of IL-2 expression.
260 _ _ |a Maryland Heights, MO
|c 2025
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1752563376_3120
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a T helper (TH)17 cells are crucial for host defense in barrier organs, and their altered functionality can disrupt tissue homeostasis, increasing the risk of autoimmune diseases. Thus, it is essential to understand the mechanisms controlling TH17 differentiation to develop strategies influencing their role in diseases. Here, we identified Special AT-rich sequence-binding protein 1 (Satb1) as a pioneering factor for TH17 development. Satb1 is highly expressed in TH17 cells, and loss of Satb1 prevents the differentiation of TH17 cells. Consequently, expression of Satb1 in CD4+ T cells is required for the formation of TH17-driven autoimmune diseases. Mechanistically, Satb1 mediates TH17 development through regulating accessibility of the Il2 gene locus and thereby preventing interleukin (IL)-2 signaling early during TH17 differentiation. Hence, suppression of IL-2 expression by Satb1 during TH17 formation is pivotal, suggesting that Satb1 could serve as a novel therapeutic target for treating autoimmune diseases driven by TH17 cells.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a CD4(+) T cell differentiation
|2 Other
650 _ 7 |a CP: Immunology
|2 Other
650 _ 7 |a EAE
|2 Other
650 _ 7 |a IL-2
|2 Other
650 _ 7 |a Satb1
|2 Other
650 _ 7 |a T(H)17 cells
|2 Other
650 _ 7 |a autoimmune disease
|2 Other
650 _ 7 |a colitis
|2 Other
650 _ 7 |a scRNA-seq
|2 Other
650 _ 7 |a single-cell MultiOMICs
|2 Other
700 1 _ |a Shakiba, Mehrnoush Hadaddzadeh
|0 P:(DE-2719)2814240
|b 1
|u dzne
700 1 _ |a Schmidleithner, Lisa
|0 P:(DE-2719)2812337
|b 2
700 1 _ |a Schulte-Schrepping, Jonas
|0 P:(DE-2719)9001500
|b 3
|u dzne
700 1 _ |a Scholz, Rebekka
|0 P:(DE-2719)9001595
|b 4
|u dzne
700 1 _ |a Elmzzahi, Tarek
|0 P:(DE-2719)9000539
|b 5
|u dzne
700 1 _ |a Sommer, Daniel
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Li, Yuanfang
|0 P:(DE-2719)9001790
|b 7
|u dzne
700 1 _ |a Carraro, Caterina
|0 P:(DE-2719)9001303
|b 8
|u dzne
700 1 _ |a De Domenico, Elena
|0 P:(DE-2719)9000846
|b 9
|u dzne
700 1 _ |a Wißfeld, Jannis
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Händler, Kristian
|0 P:(DE-2719)2812735
|b 11
|u dzne
700 1 _ |a Hamada, Doaa
|0 P:(DE-2719)9000568
|b 12
|u dzne
700 1 _ |a Frolov, Aleksej
|0 P:(DE-2719)9002087
|b 13
|u dzne
700 1 _ |a Cheng, Xiaoxiao
|0 P:(DE-2719)9002527
|b 14
|u dzne
700 1 _ |a Baumgart, Ann-Kathrin
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Holsten, Lisa
|0 P:(DE-2719)9001067
|b 16
|u dzne
700 1 _ |a Osei-Sarpong, Collins
|0 P:(DE-2719)2813660
|b 17
|u dzne
700 1 _ |a Bourry, Svenja
|0 P:(DE-2719)2811740
|b 18
700 1 _ |a Thabet, Yasser
|b 19
700 1 _ |a Renken, Hannes
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Paulusch, Stefan
|0 P:(DE-2719)9002116
|b 21
|u dzne
700 1 _ |a Sadlon, Timothy
|b 22
700 1 _ |a Buch, Thorsten
|b 23
700 1 _ |a Wunderlich, F Thomas
|b 24
700 1 _ |a Wickenhauser, Claudia
|b 25
700 1 _ |a Alferink, Judith
|b 26
700 1 _ |a Kuhlmann, Tanja
|b 27
700 1 _ |a Geyer, Matthias
|b 28
700 1 _ |a Bonaguro, Lorenzo
|0 P:(DE-2719)9001512
|b 29
|u dzne
700 1 _ |a Barry, Simon C
|b 30
700 1 _ |a Schultze, Joachim L
|0 P:(DE-2719)2811660
|b 31
|u dzne
700 1 _ |a Beyer, Marc D
|0 P:(DE-2719)2812219
|b 32
|e Last author
|u dzne
773 _ _ |a 10.1016/j.celrep.2025.115866
|g Vol. 44, no. 7, p. 115866 -
|0 PERI:(DE-600)2649101-1
|n 7
|p 115866
|t Cell reports
|v 44
|y 2025
|x 2211-1247
856 4 _ |u https://pub.dzne.de/record/279433/files/DZNE-2025-00764%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/279433/files/DZNE-2025-00764.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/279433/files/DZNE-2025-00764.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:279433
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2812698
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2814240
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2812337
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9001500
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9001595
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9000539
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)9001790
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9001303
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9000846
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2812735
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)9000568
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)9002087
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)9002527
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)9001067
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2813660
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)2811740
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)9002116
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 29
|6 P:(DE-2719)9001512
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2811660
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 32
|6 P:(DE-2719)2812219
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 1
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-16
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL REP : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T08:49:39Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T08:49:39Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T08:49:39Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-16
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CELL REP : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-16
920 1 _ |0 I:(DE-2719)1013035
|k AG Beyer
|l Immunogenomics and Neurodegeneration
|x 0
920 1 _ |0 I:(DE-2719)1013038
|k AG Schultze
|l Clinical Single Cell Omics (CSCO) / Systems Medicine
|x 1
920 1 _ |0 I:(DE-2719)1016005
|k AG Bonaguro
|l Molecular and Translational Immunaging
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013035
980 _ _ |a I:(DE-2719)1013038
980 _ _ |a I:(DE-2719)1016005
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21